Charles H. Nightingale
-
- Antibiotic Use and Resistance 30
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 79
- Pharmacology top 0.1%
- Antibiotics Pharmacokinetics and Efficacy 144
- Clinical Biochemistry top 0.5%
- Epidemiology top 1%
- Pneumonia and Respiratory Infections 60
- Pneumocystis jirovecii pneumonia detection and treatment 13
-
- Antimicrobial Resistance in Staphylococcus 25
-
- Pharmaceutical studies and practices 23
-
- Drug Transport and Resistance Mechanisms 16
- Co-authors
- David P. NicolauRichard QuintilianiJoseph L. KutiPamela R. TessierChonghua LiDouglas S. GreeneMelinda K. LacyDana Maglio
- Journals
- Clinical Infectious Diseases (4 papers)The American Journal of Medicine (3 papers)Antimicrobial Agents and Chemotherapy (22 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Charles H. Nightingale
206 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 147
- Applied Microbiology and Biotechnology 825
- Molecular Medicine 1.9k
- Pharmacology 3.1k
- Clinical Biochemistry 525
- Epidemiology 2.0k
Countries citing papers authored by Charles H. Nightingale
This map shows the geographic impact of Charles H. Nightingale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Nightingale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Nightingale more than expected).
Fields of papers citing papers by Charles H. Nightingale
This network shows the impact of papers produced by Charles H. Nightingale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Nightingale. The network helps show where Charles H. Nightingale may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles H. Nightingale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 54 | |
| 2 | 2005 | 4 | |
| 3 | 2003 | 9 | |
| 4 | 2003 | 55 | |
| 5 | 2003 | 10 | |
| 6 | 2003 | 4 | |
| 7 | 2003 | 6 | |
| 8 | 2002 | 3 | |
| 9 | 2001 | 5 | |
| 10 | 2001 | 6 | |
| 11 | 2001 | 3 | |
| 12 | 2000 | 167 | |
| 13 | 2000 | 71 | |
| 14 | 1999 | 6 | |
| 15 | 1999 | 34 | |
| 16 | 1995 | 29 | |
| 17 | 1994 | 1 | |
| 18 | 1988 | 7 | |
| 19 | 1988 | 4 | |
| 20 | 1982 | 18 |
About Charles H. Nightingale
Charles H. Nightingale is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 209 papers that have together received 5.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (144 papers), Antibiotic Resistance in Bacteria (79 papers), Pneumonia and Respiratory Infections (60 papers), Antibiotic Use and Resistance (30 papers), Antimicrobial Resistance in Staphylococcus (25 papers), Pharmaceutical studies and practices (23 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (825 citations), Molecular Medicine (1.9k citations) and Pharmacology (3.1k citations). Charles H. Nightingale has collaborated with scholars based in United States, China and Japan. Frequent co-authors include David P. Nicolau, Richard Quintiliani, Joseph L. Kuti, Pamela R. Tessier, Chonghua Li, Douglas S. Greene, Melinda K. Lacy, Dana Maglio, Prachi K. Dandekar and JoCarol McNabb. Their work appears in journals such as Clinical Infectious Diseases, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.